Paper Details

  1. Home
  2. Paper Details

Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.

Author: EngelaarH F, HermansM B, LeeringC, MunnichsJ M, van Loveren-HuybenC M, van der BomJ A

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Ergoloid mesylates significantly improved symptoms of senile mental deterioration compared to placebo in residents of old people's homes, with marked individual differences in the degrees of improvement.
Paper Details　
Original Abstract of the Article :
A double-blind study of 24 weeks' duration was conducted to investigate the effects of ergoloid mesylates (Hydergine) on symptoms of senile mental deterioration. Fifty-eight residents of old people's homes were included in the trial. Thirty were treated with ergoloid mesylates and 28 with placebo, a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1532-5415.1984.tb06137.x

データ提供：米国国立医学図書館（NLM）

Ergoloid Mesylates: A Oasis of Hope in the Desert of Senile Mental Deterioration

The desert of senile mental deterioration is a challenging landscape, where cognitive decline and memory loss can leave individuals feeling lost and isolated. This study explored the potential benefits of ergoloid mesylates, a medication commonly used to treat symptoms of senile mental deterioration, in a double-blind trial. The researchers set out to determine the impact of this medication on cognitive function and behavior, searching for a path to improved mental well-being.

Ergoloid Mesylates: A Potential Source of Relief in the Desert of Cognitive Decline

The study found that ergoloid mesylates showed promising results in improving cognitive function in patients with senile mental deterioration. The participants who received ergoloid mesylates showed significant improvement on the Sandoz Clinical Assessment Geriatric Scale (SCAG), a measure of cognitive function. The researchers observed a close correlation between improved cognitive function scores and positive changes in behavior, suggesting that this medication may offer a potential oasis of relief in the desert of cognitive decline.

The Desert of Senile Mental Deterioration: A Journey of Hope and Support

This study provides valuable insights into the potential benefits of ergoloid mesylates in managing senile mental deterioration. While more research is needed to fully understand the long-term effects of this medication, the study's findings offer a glimmer of hope for those navigating the challenges of this condition. The researchers' work highlights the importance of ongoing research and development of effective treatments for those facing the challenges of cognitive decline.

Dr.Camel's Conclusion

This study provides a beacon of hope in the desert of senile mental deterioration. The researchers' findings suggest that ergoloid mesylates may offer a potential source of relief for those facing the challenges of cognitive decline. The study underscores the importance of continued research and development of effective treatments for those who are lost in this challenging landscape.

Date :
  1. Date Completed 1984-09-07
  2. Date Revised 2019-07-09
Further Info :

Pubmed ID

6379022

DOI: Digital Object Identifier

10.1111/j.1532-5415.1984.tb06137.x

Related Literature

Article Analysis
・Effects of ergoloid mesylates
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.